Gilead Sciences revenue

Gilead Sciences revenue decreased from $26.1 billion in 2017 to $22.1 billion in 2018, a 15.2% decrease.

Annual Revenue ($)

Gilead Sciences revenue was $22.13 b in FY, 2018

Quarterly Revenue ($)

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018
Revenue$11.20 b$24.89 b$32.64 b$30.39 b$26.11 b$22.13 b
Growth122.2%31.13%(6.89%)
Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q3, 2018Q1, 2019Q2, 2019
Revenue$2.78 b$5 b$6.53 b$6.04 b$7.59 b$8.24 b$8.30 b$7.79 b$7.78 b$7.50 b$6.51 b$7.14 b$6.51 b$5.09 b$5.60 b$5.28 b$5.69 b

Annual Growth Rate (%)

Revenue Breakdown

Geographic Segment

Gilead Sciences revenue breakdown by geographic segment: 8.3% from Japan, 63.7% from United States, 20.9% from Europe and 7.1% from Other

FY, 2014FY, 2015FY, 2016
Japan53 m1.94 b2.53 b
Other1.21 b1.94 b2.14 b
United States18.18 b21.23 b19.35 b
Europe5.44 b7.53 b6.37 b